These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Pleuropulmonary disease associated with dopamine agonist therapy. Bhatt MH; Keenan SP; Fleetham JA; Calne DB Ann Neurol; 1991 Oct; 30(4):613-6. PubMed ID: 1686385 [TBL] [Abstract][Full Text] [Related]
8. The role of bromocriptine in the treatment of Parkinson's disease. Stern GM; Lees AJ; Shaw KM; Lander CM Adv Biochem Psychopharmacol; 1980; 23():267-70. PubMed ID: 7395617 [No Abstract] [Full Text] [Related]
9. [Pleural effusion induced by bromocriptine]. Diot E; Diot P; Le Rolland A; Jonville AP; Lasfargues G; Lemarie E; Lavandier M; Guilmot JL Rev Mal Respir; 1990; 7(2):175-7. PubMed ID: 2320790 [TBL] [Abstract][Full Text] [Related]
10. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine]. Montastruc JL; Schmitt L; Bagheri H Rev Neurol (Paris); 2003 Apr; 159(4):441-3. PubMed ID: 12773874 [TBL] [Abstract][Full Text] [Related]
11. [A comparative study of the effect of bromocriptine and pergolide on Parkinson disease]. de Yébenes JG; García-Ruiz PJ; Sánchez-Pernaute R Rev Neurol; 1997 Sep; 25(145):1343-5. PubMed ID: 9377286 [TBL] [Abstract][Full Text] [Related]
12. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study. Im JH; Ha JH; Cho IS; Lee MC J Neurol; 2003 Jan; 250(1):90-6. PubMed ID: 12527999 [TBL] [Abstract][Full Text] [Related]
13. Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease. Hauser RA; Koller WC; Hubble JP; Malapira T; Busenbark K; Olanow CW Mov Disord; 2000 May; 15(3):485-9. PubMed ID: 10830413 [TBL] [Abstract][Full Text] [Related]